Docetaxel toxicity and activity in anthracycline-pretreated metastatic breast cancer (MBC)
Michele Stanislaw Milella(University of Verona), F. Cognetti(Sapienza University of Rome), A. Marsella, Cecilia Nisticò(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Angela Vaccaro(Accademia di Belle Arti di Frosinone), Maria Francesca Thorel(Cancer Institute (WIA)), Maria Cecilia Cercato, Armando Carpino(Cancer Institute (WIA)), Paola Papaldo(Cancer Institute (WIA)), E. Terzoli(Catholic University of America), A.M. D'Ottavio(Cancer Institute (WIA)), Virginia Ferraresi(Cancer Institute (WIA))
Cited by 0
Related Papers
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k
Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
|New England Journal of Medicine|2016|1.3k
Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial
|The Lancet Oncology|2015|1.3k